CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Anika Therapeutics, Inc.  (ANIK)
Other Ticker:  
 
 

ANIK's Operating Income Growth by Quarter and Year

Anika Therapeutics,'s Operating Income results by quarter and year




ANIK Operating Income (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December 9.76 9.73 12.74 17.07
III Quarter September 8.57 10.27 13.69 13.14
II Quarter June 11.25 17.73 13.47 12.43
I Quarter March -7.83 8.01 10.71 5.50
FY   21.75 45.74 50.61 48.14



ANIK Operating Income forth quarter 2018 Y/Y Growth Comment
Anika Therapeutics, Inc. reported Operating Income growth of 0.33% year on year in the forth quarter, to $ 9.76 millions, this is lower than Anika Therapeutics, Inc.'s recent average Operating Income growth of 2.03%.

Looking into forth quarter results within Medical Equipment & Supplies industry 37 other companies have achieved higher Operating Income growth. While Anika Therapeutics, Inc.' s Operating Income increase of 0.33% ranks overall at the positon no. 1442 in the forth quarter.

Explain Operating Income growth


ANIK Operating Income ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December 0.33 % -23.63 % -25.37 % 41.19 %
III Quarter September -16.55 % -24.98 % 4.19 % 27.7 %
II Quarter June -36.55 % 31.63 % 8.37 % -18.22 %
I Quarter March - -25.21 % 94.73 % -76.96 %
FY   -52.44 % -9.62 % 5.13 % -

Financial Statements
Anika Therapeutics,'s forth quarter 2018 Operating Income $ 9.76 millions ANIK's Income Statement
Anika Therapeutics,'s forth quarter 2017 Operating Income $ 9.73 millions Quarterly ANIK's Income Statement
New: More ANIK's historic Operating Income Growth >>


ANIK Operating Income (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December 13.91 % -5.26 % -6.94 % 29.91 %
III Quarter September -23.82 % -42.08 % 1.63 % 5.71 %
II Quarter June - 121.35 % 25.77 % 126 %
I Quarter March - -37.13 % -37.26 % -54.51 %
FY (Year on Year)   -52.44 % -9.62 % 5.13 % -




Operating Income forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #102
Overall #1442

Operating Income Y/Y Growth Statistics
High Average Low
42.68 % 2.03 % -34.63 %
(March 31, 2014)   (Mar 31 2018)
Operating Income forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #102
Overall #1442
Operating Income Y/Y Growth Statistics
High Average Low
42.68 % 2.03 % -34.63 %
(March 31, 2014)   (Mar 31 2018)

Operating Income by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Anika Therapeutics,'s Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
185.74 % 18.72 % -55.55 %
(Dec 31 2012)  


ANIK's IV. Quarter Q/Q Operating Income Comment
Anika Therapeutics, Inc. achieved in the IV. Quarter 2018 below company average Operating Income rise of 13.91% quarter on quarter, to $ 9.76 millions.

Albeit the IV. Quarter 2018 Anika Therapeutics,'s Operating Income Q/Q growth was below the average of 18.72 %, this has been yet encouraging sign, as the IV. Quarter improvement, outshines the -5.26% rise in the IV. Quarter 2017

Within Medical Equipment & Supplies industry 18 other companies have achieved higher Operating Income quarter on quarter growth. While Anika Therapeutics,'s Operating Income growth quarter on quarter, overall rank is 722.


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #19
Healthcare Sector #57
Overall #722
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #19
Healthcare Sector #57
Overall #722
Operating Income Q/Q Growth Statistics
High Average Low
185.74 % 18.72 % -55.55 %
(Dec 31 2012)  


ANIK's IV. Quarter Q/Q Operating Income Comment
Anika Therapeutics, Inc. achieved in the IV. Quarter 2018 below company average Operating Income rise of 13.91% quarter on quarter, to $ 9.76 millions.

IV. Quarter 2018 ANIK's Operating Income quarter on quarter growth seem to be a mixed bag, although beneath the average rise of 18.72 %, yet it demonstrates absolute improvement compare to the -5.26% in the IV. Quarter a year ago.

Within Medical Equipment & Supplies industry 18 other companies have achieved higher Operating Income quarter on quarter growth. While Anika Therapeutics,'s Operating Income growth quarter on quarter, overall rank is 722.


Anika Therapeutics,'s 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
Cumulative Operating Income 12 Months Ending $ 21.75 $ 21.72 $ 23.41 $ 29.89 $ 45.73
Y / Y Operating Income Growth (TTM) -52.44 % -55.45 % -55.12 % -37.6 % -9.64 %
Year on Year Operating Income Growth Overall Ranking # 2102 # 425 # 1823 # 2013 # 1335
Seqeuential Operating Income Change (TTM) 0.16 % -7.24 % -21.68 % -34.63 % -6.18 %
Seq. Operating Income Growth (TTM) Overall Ranking # 1442 # 420 # 1894 # 2315 # 1747




Cumulative Operating Income growth Comment
Anika Therapeutics, showed decline, but improvement compare to trailing twelve month Operating Income decrease in Sep 30 2018. If the fiscal year would end in Dec 31 2018, Anika Therapeutics,'s annual Operating Income decline would be -52.44% year on year to $22 millions.

In the Healthcare sector 130 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 425 to 2102.

Operating Income TTM Q/Q Growth Statistics
High Average Low
42.68 %
2.03 %
-34.63 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 38
Healthcare Sector # 131
Overall # 2102

Operating Income TTM Y/Y Growth Statistics
High Average Low
172.63 %
10.65 %
-55.45 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 38
Sector # 102
S&P 500 # 1442
Cumulative Operating Income growth Comment
Anika Therapeutics, showed decline, but improvement compare to trailing twelve month Operating Income decrease in Sep 30 2018. If the fiscal year would end in Dec 31 2018, Anika Therapeutics,'s annual Operating Income drop would be -52.44% year on year to $22 millions.

In the Healthcare sector 130 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 425 to 2102.

Operating Income TTM Q/Q Growth Statistics
High Average Low
42.68 %
2.03 %
-34.63 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 38
Healthcare Sector # 131
Overall # 2102

Operating Income TTM Y/Y Growth Statistics
High Average Low
172.63 %
10.65 %
-55.45 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 38
Sector # 102
S&P 500 # 1442




Other Operating Income Growth
Medical Equipment & Supplies Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ANIK's Operating Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ANIK's Competitors
Operating Income Growth for Anika Therapeutics,'s Suppliers
Operating Income Growth for ANIK's Customers

You may also want to know
ANIK's Annual Growth Rates ANIK's Profitability Ratios ANIK's Asset Turnover Ratio ANIK's Dividend Growth
ANIK's Roe ANIK's Valuation Ratios ANIK's Financial Strength Ratios ANIK's Dividend Payout Ratio
ANIK's Roa ANIK's Inventory Turnover Ratio ANIK's Growth Rates ANIK's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending Dec 31 2018 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2018
Anika Therapeutics, Inc.  0.35 %$ 0.350 millions
Atrion Corp  0.30 %$ 0.301 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AANC's Profile

Stock Price

AANC's Financials

Business Description

Fundamentals

Charts & Quotes

AANC's News

Suppliers

AANC's Competitors

Customers & Markets

Economic Indicators

AANC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071